Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 599.4765 ↑ 2.2%
[as on 6 May, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option and its peers as on 6 May, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 5.26% 2.2% 3.31% 10.04% 7.93% 9.49% 24.71% 14.55% 20.89% 15.97%
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -4.16% 0.71% 0.2% 7.63% -0.15% -2.63% 12.57% 16.83% 15.57% 16%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -4.79% 1.29% 0.8% 7.64% -3.08% 3.05% 13.02% 12.21% 13.05% 13.31%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 8.33% 1.61% 3.72% 10.83% 10.77% 9.26% 27.44% 17.03% 22.34% 13.99%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.7% 0.3% 0.59% 14.47% 4.83% 9.37% 21.99% 21.72% 19.97% 16.9%
SBI PSU Fund - DIRECT PLAN - GROWTH 7.09% 1.05% -0.19% 7.83% 2.87% 21.25% 32.17% 27.94% 21.02% 17.03%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -9.42% 8.09% 4.71% 2.97% 68.53% 23.84% -9.16% 41.33% 35.46% -2.94%

Discrete returns (monthly)

MonthJul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026
Returns 2.66% -1.41% -2.52% 2.24% 0.9% -1.24% -4.66% 5.31% -4.85% 6.03%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.72% 2.51%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.45% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.55%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology8.45%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.41%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.96%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.42%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.86%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.36%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.15%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.15%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.87%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.81%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.77%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.64%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.43%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.17%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.02%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.94%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.90%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.72%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.67%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.51%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.16%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.12%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.11%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology0.94%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.93%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.89%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.88%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.67%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.62%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.38%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.14%
Portfolio data is as on date 31 March, 2026

NAV history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
6 May, 2026599.4765 2.2%
5 May, 2026586.5475 -0.13%
4 May, 2026587.3048 1.26%
30 April, 2026579.9839 -0.05%
29 April, 2026580.2930 0.29%
28 April, 2026578.6001 -0.36%
27 April, 2026580.6636 2.11%
24 April, 2026568.6673 -1.15%
23 April, 2026575.2846 1.39%
22 April, 2026567.4146 0.35%
21 April, 2026565.4599 0.18%
20 April, 2026564.4158 -0.27%
17 April, 2026565.9347 0.32%
16 April, 2026564.1348 -0.14%
15 April, 2026564.9044 1.41%
13 April, 2026557.0463 -0.13%
10 April, 2026557.7510 0.65%
9 April, 2026554.1348 0.67%
8 April, 2026550.4254 0.79%
7 April, 2026546.0989 0.24%
6 April, 2026544.8019 0.15%
2 April, 2026543.9665 -0.56%
1 April, 2026547.0158 -0.35%
31 March, 2026548.9228 0%
30 March, 2026548.9359 -1.18%
27 March, 2026555.4694 -0.94%
25 March, 2026560.7225 1.58%
24 March, 2026552.0262 1.16%
23 March, 2026545.6965 -2.02%
20 March, 2026556.9533

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 599.4765 as on 6 May, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 5.26% as on 6 May, 2026.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 9.49% as on 6 May, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 24.71% as on 6 May, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.55% as on 6 May, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.55% as on 6 May, 2026.